Intervention Arm - CHW-led curriculum (Group 2) for COVID-19 Testing

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Charles Drew University of Medicine and Science, Los Angeles, CA
COVID-19 Testing+3 More
Community Health Worker led curriculum - Behavioral
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

The objective of this study is to compare the results of a COVID-19 specific curriculum led by LACDHS Community Health Workers (CHWs) from these same communities of safety-net patients to effectively increase COVID-19 testing and vaccination for individual patients, and to facilitate needed healthcare in a timely manner for the safety net health system, and to develop a sustained public health presence in these communities to build trust and preparedness for critical COVID-19 related future needs.

Eligible Conditions

  • COVID-19 Testing
  • Community Health Workers
  • Vaccine Hesitancy

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Six weeks from start of project

Six weeks from start of project
Increase health literacy regarding COVID-19 testing and vaccination
Measure three key measures: trust, self-efficacy, and intent to participate in COVID-19 testing and vaccination

Trial Safety

Trial Design

2 Treatment Groups

Control Arm - Standard Treatment (Group 1)
1 of 2
Intervention Arm - CHW-led curriculum (Group 2)
1 of 2
Active Control
Experimental Treatment

142 Total Participants · 2 Treatment Groups

Primary Treatment: Intervention Arm - CHW-led curriculum (Group 2) · No Placebo Group · N/A

Intervention Arm - CHW-led curriculum (Group 2)
Behavioral
Experimental Group · 1 Intervention: Community Health Worker led curriculum · Intervention Types: Behavioral
Control Arm - Standard Treatment (Group 1)NoIntervention Group · 1 Intervention: Control Arm - Standard Treatment (Group 1) · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: six weeks from start of project
Closest Location: Charles Drew University of Medicine and Science · Los Angeles, CA
Photo of Los Angeles  1Photo of Los Angeles  2Photo of Los Angeles  3
2010First Recorded Clinical Trial
1 TrialsResearching COVID-19 Testing
13 CompletedClinical Trials

Eligibility Criteria

Age Any Age · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.